Cleared Traditional

K082130 - EUROIMMUN ANTI-PR3-HN-HR ELISA (IGG)

K082130 is an FDA 510(k) clearance for EUROIMMUN ANTI-PR3-HN-HR ELISA (IGG), manufactured by Euroimmun Us, Inc.. The device is a Class 2 Immunology device with product code MOB cleared through the Traditional 510(k) pathway after a 252-day FDA review.

K082130 · Euroimmun Us, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
252d
Days
Class 2
Risk

K082130 is an FDA 510(k) clearance for the EUROIMMUN ANTI-PR3-HN-HR ELISA (IGG). Classified as Test System, Antineutrophil Cytoplasmic Antibodies (anca) (product code MOB), Class II - Special Controls.

Submitted by Euroimmun Us, Inc. (Morristown, US). The FDA issued a Cleared decision on April 7, 2009 after a review of 252 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Euroimmun Us, Inc. devices

FDA 510(k) Submission Details - K082130

510(k) Number K082130 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 29, 2008
Decision Date April 07, 2009
Days to Decision 252 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
147d slower than avg
Panel avg: 105d · This submission: 252d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MOB Device Classification - Class 2, Special Controls

Product Code MOB Test System, Antineutrophil Cytoplasmic Antibodies (anca)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - MOB Test System, Antineutrophil Cytoplasmic Antibodies (anca)

All 62
Devices cleared under the same product code (MOB) and FDA review panel - the closest regulatory comparables to K082130.
IMMULISA PR3 ANTIBODY ELISA
K092600 · Immco Diagnostics, Inc. · Oct 2010
IMMULISA ANCA SCREEN ELISA
K092601 · Immco Diagnostics, Inc. · Oct 2010
EUROIMMUN ANCA IFA EUROPLUS GRANULOCYTE BIOCHIP MOSAIC TEST SYSTEMS
K083850 · Euroimmun Us, Inc. · May 2009
EL-ANCA: ANTI-MPO, ANTI-PR3, ANTI-MPO AND ANTI-PR3
K061376 · Theratest Laboratories, Inc. · Jul 2006
EUROIMMUN ANCA IFA GRANULOCYTE BIOCHIP MOSCAIC IGG ANTIBODY IN HUMAN SERUM
K051489 · Euroimmun Us, LLC · Feb 2006
WIESLAB CAP MPO-ANCA
K051455 · Eurodiagnostica · Nov 2005